Expression and prognostic value of C-reactive protein in adult immune thrombocytopenia (ITP) patients.

Autor: Zhang, YaNan, Liu, FengAn, Liang, XiuLi, Zhu, JingJing, Han, Li, Shi, XueDong, Cao, Jiang, Li, ZhenYu, Chen, Wei, Xu, KaiLin, Cheng, Hai

Publikováno v: Clinical & Experimental Medicine; Dec2023, Vol. 23 Issue 8, p4483-4491, 9p

Impact of glucocorticoids on short-term and long-term outcomes in patients with relapsed/refractory multiple myeloma treated with CAR-T therapy.

Autor: Wang X; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Qi Y; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Li H; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Liu F; Xuzhou Medical University, Xuzhou, China., Cao J; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Chen W; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Wang Y; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Qi K; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Yan Z; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Zhu F; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Li Z; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Cheng H; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Xu K; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Aug 23; Vol. 13, pp. 943004. Date of Electronic Publication: 2022 Aug 23 (Print Publication: 2022).